News & Updates
Filter by Specialty:
Tirzepatide lowers HbA1c, body weight in adults with T2D
Treatment with tirzepatide once weekly results in significant decreases in glycated haemoglobin A1c (HbA1c) and body weight (BW), regardless of antiglutamic acid decarboxylase autoantibodies (GADA) status in adults with type 2 diabetes (T2D), according to a post hoc analysis of SURPASS.
Tirzepatide lowers HbA1c, body weight in adults with T2D
01 Apr 2025
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
In the absence of infant hepatitis B immune globulin (HBIg), maternal tenofovir disoproxil fumarate (TDF) prophylaxis combined with infant hepatitis B virus (HBV) immunization provide sufficient protection against HBV infection in infants, findings from the iTAP-2 study suggest. However, the risk of infection was not demonstrably below 2 percent.
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025
Lebrikizumab relieves itch, skin pain in AD patients previously on dupilumab
The use of lebrikizumab improves the symptoms of moderate-to-severe atopic dermatitis (AD) in patients previously treated with dupilumab, reports a study presented at AAD 2025.
